These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8946204)

  • 1. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers.
    Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J
    Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer.
    Komiya A; Suzuki H; Ueda T; Yatani R; Emi M; Ito H; Shimazaki J
    Genes Chromosomes Cancer; 1996 Dec; 17(4):245-53. PubMed ID: 8946206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer.
    Elo JP; Härkönen P; Kyllönen AP; Lukkarinen O; Poutanen M; Vihko R; Vihko P
    Cancer Res; 1997 Aug; 57(16):3356-9. PubMed ID: 9269995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.
    Ueda T; Emi M; Suzuki H; Komiya A; Akakura K; Ichikawa T; Watanabe M; Shiraishi T; Masai M; Igarashi T; Ito H
    Genes Chromosomes Cancer; 1999 Mar; 24(3):183-90. PubMed ID: 10451697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient.
    Elo JP; Härkönen P; Kyllönen AP; Lukkarinen O; Vihko P
    Br J Cancer; 1999 Jan; 79(1):156-60. PubMed ID: 10408707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.
    Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T
    Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer.
    Härkönen P; Kyllönen AP; Nordling S; Vihko P
    Prostate; 2005 Feb; 62(3):267-74. PubMed ID: 15389780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.
    Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S
    Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer.
    Li C; Berx G; Larsson C; Auer G; Aspenblad U; Pan Y; Sundelin B; Ekman P; Nordenskjöld M; van Roy F; Bergerheim US
    Genes Chromosomes Cancer; 1999 Mar; 24(3):175-82. PubMed ID: 10451696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
    Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.
    Chen T; Sahin A; Aldaz CM
    Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
    Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
    Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
    Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recessive genetic mechanisms in the oncogenesis of prostatic carcinoma.
    Bergerheim US; Collins VP; Ekman P; Kunimi K
    Scand J Urol Nephrol Suppl; 1991; 138():93-6. PubMed ID: 1686123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
    Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
    Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
    Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
    Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.